StockData
ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31

Adlai Nortye Group Ltd.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 10, 2026
$10.38−0.65 (-5.89%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Adlai Nortye Group Ltd. balance sheet

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
–
Operating margin
-714.0%
Net margin
-710.6%
Return on equity, FY2025
–

Financial strength

Current ratio
0.65
Debt to equity
–
Debt to assets
–
Cash to current liabilities
19.4%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–